Pfizer and Lilly Receive FDA Fast Track Designation for Tanezumab
Go back to Pfizer and Lilly Receive FDA Fast Track Designation for Tanezumab| Lilly (Eli) & Co. (NYSE: LLY) | Delayed: 1169.86 +54.18 (4.86%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1115.68 | 52 Week High | $88.16 | |||
| Open | $1174.00 | 52 Week Low | $67.88 | |||
| Day High | $1216.94 | P/E | 270.80 | |||
| Day Low | $1136.74 | EPS | $4.32 | |||
| Volume | 6,444,194 | |||||
| Pfizer Inc. (NYSE: PFE) | Delayed: 25.81 +0.40 (1.57%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $25.41 | 52 Week High | $37.39 | |||
| Open | $25.50 | 52 Week Low | $28.25 | |||
| Day High | $25.81 | P/E | 15.64 | |||
| Day Low | $25.30 | EPS | $1.65 | |||
| Volume | 47,106,430 | |||||
